This decrease of CD4 + /CD8 + T lymphocyte ratio was highly significant compared to acute cases (P = 0.038).
← all phrases
“highly significant”
Sighted at
p=0.09
In the literature
Worthy of note is the highly significant decrease of sensitivity among the PTB patients in Heilongjiang (from 72.2% to 59.4%) ( p = 0.038), which was not the case in Zhejiang (from 98.7% to 97.3%) ( p = 0.68).
The combination of DHC with DOX caused highly significant reduction in Hb levels as compared to DOX (** P<0.038) and DHC (** * P <0.022) alone.
The fastest decline was noted in the control group, with pain scores higher in the study group, but with no significant association except that statistical hypotheses demonstrated a highly significant difference (p = 0.038) with a large effect size (0.385) on D3 (Table 5 ).
Even after correcting for baseline variability, the superior ADG of the T2 group remained highly significant ( p = 0.038).
The interaction test between the outcomes of obstructive versus nonobstructive CAD was highly significant ( P =0.038) (Table S7 ).
Additionally, current smoking showed a highly significant association with low adherence to oral 5-ASA (current smoking: OR 4.06, 95% CI 1.08–15.18, p = .038).
The marginal model also revealed that the factor score “2” quintiles and time interaction on the number of COVID-19 patients were highly significant (X 2 = 10.094, df = 4, P = 0.039).
regular universal primers) there was a highly significant difference between the read abundance of bifidobacteria using ‘bifidobacteria-optimised’ primers compared to regular primers ( P = 0.039, t = 0.0026, with Bonferonni correction for multiple testing), but no significant differences between any of the other OTUs ( P >1.4).
Only in XPC exon-15 (2920 A>C, rs2228001) polymorphism, the C allele had highly significant protective effect (p=0.039) on the risk of developing severe toxicity reactions in normal skin of HNC patients in response to radiotherapy.
Also, constipation is has a highly significant effect on a patient’s well-being. 72 Likely, in our case, grade≥2 peripheral neuropathy and constipation (4.819≤B≤26.451, P≤0.039) were also the other toxicities of AC and AC-T breast cancer chemotherapy that frequently associated with deterioration of symptom scales/items like fatigue, pain, dyspnea, constipation, diarrhea and/or systemic therapy side effects than their lower-grade counterparts.
In particular, when both parents and child tested positive, the high initial CARS score dropped after therapy but this did not represent a highly significant change (p=0.0398).
For medication misuse, the differences were as expected and highly significant, meaning that interactivity clearly helped to curb this deteriorating behavior both at midterm assessment (mean difference=−1.5, P =.04, d =0.28) and final assessment (mean difference=−1.6, P =.03, d =−0.55).
Highly significant differences in genotype distribution (Pg = 0.001) and in allelic frequencies ( p = 0.04) were proved between patients treated with interferon α therapy and those who were not.
In the univariate analysis, a highly significant association of chronic kidney disease (CKD) history (OR 4.846, p = 0.04), CVP at admission (OR: 1.185, p = 0–014), SvO 2 at admission (OR 0.942, p < 0.001) and GFR at admission GFR at admission (OR 0.951, p = 0.002) with the development of AKI could be demonstrated.
The gene expression of the CYP1A1 in blood after 15 days in the Group of 200 mg was significantly reduced by 31% ( p = 0.032) and more importantly for the reduction for the CYP2B6 was highly significant by 87% ( p = 0.040).
The results were highly significant, with 56% survival at 5 years for the treated group and 31% for the control group (p = 0.04).
Patients who developed AKI and need to dialysis showed higher level of NGAL at day 0 compared to patients who developed AKI without need to dialysis and patients who did not develop AKI, but with no statistical significance, while at 3rd day, it markedly increased (median = 350 ng/mL) and became highly significant ( P = 0.04).
The test for overall heterogeneity was highly significant (Q(4) = 10.14, p = 0.04), reflecting the notable variability in the results.
The difference between the groups is statistically highly significant ( P = 0.04).
Compared to controls and using the C/C genotype as a reference, women heterozygous at -509 had an 18% decrease in risk of ER+ breast cancer (OR 0.82, 95% CI 0.67 – 1.00), women homozygous for the T allele had a 38% decrease in risk (OR 0.62, 95% CI 0.42 – 0.90), and there was a highly significant trend in decreased risk across these two genotypes (p = 0.04 for L10P and p = 0.005 for -509).
There were highly significant differences concerning 7- ( p = 0.04) and 30-day mortality ( p = 0.002).
The difference in R between E-lig + and α4β7 + Th cells from experimental, but not control, BMCs was highly significant (P < 0.04).
Similar results were observed with OCR, which was associated with a highly significant reduction in the risk of relapse at 1 year compared to FTY, with a hazard ratio of 3.4 ( P = 0.04). 114 Finally, there are few data to support the use of CLA in this situation.
The differences in percentage of akinesia between Preop and FU 1, and between FU 2 and FU 3, were not significant, but the other comparisons were highly significant, with the values decreasing from 30.4 ± 7.5 (Preop) to 29.3 ± 4.2 (FU 1), 19.8 ± 11.6 (FU 2, P = 0.04 vs FU 1), and 14.5 ± 7.2 (FU 3, P < 0.001 vs FU 1).